An indirect enzyme-linked immunosorbent assay for rapid and quantitative assessment of Type III virulence phenotypes of Pseudomonas aeruginosa isolates

Annals of Clinical Microbiology and Antimicrobials

Volumn 4, Issue , 2005, Pages

  Li, Li ^a   Ledizet, Michel ^b   Kar, Kalipada ^b   Koski, Raymond A ^b   Kazmierczak, Barbara I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b L2 Diagnostics LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL ENZYME; CALCIUM; PSEUDOMONAS EXOTOXIN; VIRULENCE FACTOR; ANTIGEN V, PSEUDOMONAS; BACTERIAL PROTEIN; BACTERIAL TOXIN; MONOCLONAL ANTIBODY; PORE FORMING CYTOTOXIC PROTEIN; PSEUDOMONAS EXOPROTEIN A PROTEIN, PSEUDOMONAS AERUGINOSA;

ANTIGEN DETECTION; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELL CULTURE; CONTROLLED STUDY; CORRELATION FUNCTION; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; IMMUNOBLOTTING; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PREDICTION; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PATHOGENICITY; PSEUDOMONAS INFECTION; VIRULENCE;

ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PHENOTYPE; PORE FORMING CYTOTOXIC PROTEINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE;

EID: 30044452446     PISSN: 14760711     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-4-22     Document Type: Article

References (48)

1. JB Lyczak, CL Cannon, GB Pier: Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2000, 2:1051-1060.
2. T Yahr, LM Mende-Mueller, MB Friese, DW Frank: Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon. J. Bacteriol. 1997, 179:7165-7168.
3. TL Yahr, J Goranson, DW Frank: Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III secretion pathway. Mol. Microbiol. 1996, 22:991-1003.
4. A Roy-Burman, RH Savel, S Racine, BL Swanson, NS Revadigar, J Fujimoto, T Sawa, DW Frank, JP Wiener-Kronish: Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 2001, 183:1767-74.
5. A Hauser, E Cobb, M Bodi, D Mariscal, J Valles, J Engel, J Rello: Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 2002, 30:521-528.
6. P Berthelot, I Attree, P Plesiat, J Chabert, S de Bentzmann, B Pozzetto, F Grattard: Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginiosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes. J Infect Dis 2003, 188:512-518.
7. M Allewelt, FT Coleman, M Grout, GP Priebe, GB Pier: Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect Immun 2000, 68:3998-4004.
8. AR Hauser, PJ Kang, J Engel: PepA, a novel secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence. Mol Microbiol 1998, 27:807-818.
9. DW Frank: The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol 1997, 4:621-629.
10. G Cornelis, F Van Gijsegem: Assembly and function of type III secretory systems. Annu Rev Microbiol 2000, 54:735-774.
11. V Finck-Barbancon, J Goranson, L Zhu, T Sawa, JP Wiener-Kronish, SMJ Fleiszig, C Wu, L Mende-Mueller, D Frank: ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 1997, 25:547-557.
12. TL Yahr, AJ Vallis, MK Hancock, JT Barbieri, DW Frank: ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. U S A 1998, 95:13899-13904.
13. T Sawa, TL Yahr, M Ohara, K Kurahashi, MA Gropper, JP Wiener-Kronish, DW Frank: Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 1999, 5:392-398.
14. C Neyt, GR Cornelis: Insertion of a Yop translocation pore into the macrophage plasma membrane by Yersinia enterocolitica: requirement for translocators YopB and YopD, but not LcrG. Molecular Microbiology 1999, 33:971-81.
15. H Sato, JB Feix, CJ Hillard, DW Frank: Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU. J Bacteriol 2005, 187:1192-1195.
16. H Sato, DW Frank, CJ Hillard, JB Feix, RR Pankhaniya, K Moriyama, V Finck-Barbancon, A Buchaklain, M Lei, RM Long, et al: The mechanism of action of the Pseudomonas aeruginosa encoded type III cytotoxin, ExoU. EMBO J 2003, 22:2959-2969.
17. RM Phillips, DA Six, EA Dennis, P Ghosh: In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J Biol Chem 2003, 278:41326-41332.
18. M Tamura, T Ajayi, LR Allmond, K Moriyama, JP Wiener-Kronish, T Sawa: Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU. Biochem Biophys Res Comm 2004, 316:323-331.
19. AK Ganesan, L Mende-Mueller, J Selzer, JT Barbieri: Pseudomonas aeruginosa exoenzyme S, a double ADP-ribosyltransferase, resembles vertebrate mono-ADP-ribosyltransferases. J Biol Chem 1999, 274:9503-9508.
20. B Kazmierczak, J Engel: Pseudomonas aeruginosa ExoT acts in vivo as a GTPase activating protein for RhoA, Rac1, and Cdc42. Infect Immun 2002, 70:2198-2205.
21. R Krall, G Schmidt, K Aktories, JT Barbieri: Pseudomonas aeruginosa ExoT is a Rho GTPase-Activating Protein. Infect Immun 2000, 68:6066-6068.
22. TS Vincent, JE Fraylick, EM McGuffie, JC Olson: ADP-ribosylation of oncogenic Ras proteins by Pseudomonas aeruginosa exoenzyme S in vivo. Molecular Microbiology 1999, 32:1054-64.
23. J Sun, JT Barbieri: Pseudomonas aeruginosa ExoT ADP-ribosylates CT10-regulator of kinase (Crk) proteins. J Biol Chem 2003, 278:32794-32800.
24. CM Shaver, AR Hauser: Relative contributions of Pseudomonas aeruginosa ExoU, ExoS and ExoT to virulence in the lung. Infect Immun 2004, 72:6969-6977.
25. VT Lee, RS Smith, B Tummler, S Lory: Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect Immun 2005, 73:1695-1705.
26. GS Schulert, H Feltman, SDP Rabin, CG Martin, SE Battle, J Rello, AR Hauser: Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J Infect Dis 2003, 188:1695-1706.
27. J Goure, P Broz, O Attree, GR Cornelis, I Attree: Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. J Infect Dis 2005, 192:218-225.
28. AN Neely, IA Holder, JP Wiener-Kronish, T Sawa: Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge. Burns 2005, 31:153-8.
29. DW Frank, A Vallis, JP Wiener-Kronish, A Roy-Burman, EG Spack, BP Mullaney, M Megdoud, JD Marks, R Fritz, T Sawa: Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. Journal of Infectious Diseases. 2002, 186:64-73.
30. 2 in sepsis associated with Pseudomonas aeruginosa. J Immunol 2001, 167:5880-5886.
31. R Nordfelth, AM Kauppi, HA Norberg, H Wolf-Watz, M Elofsson: Small-molelcule inhibitors specifically targeting type III secretion. Infect Immun 2005, 73:3104-3114.
32. TI Nicas, BH Iglewski: Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S. Infect. Immun. 1984, 45:470-474.
33. MA Laskowski, E Osborn, BI Kazmierczak: A novel sensor kinase-response regulator hybrid regulates Type III secretion and is required for virulence in Pseudomonas aeruginosa. Mol Microbiol 2004, 54:1090-1103.
34. RE Vance, A Rietsch, JJ Mekalanos: Role of the Type III secreted exoenzymes S, T and Y in systemic spread of Pseudomonas aeruginosa PA01 in vivo. Infect Immun 2005, 73:1705-1713.
35. L Garrity-Ryan, B Kazmierczak, R Kowal, J Comolli, A Hauser, J Engel: The arginine finger domain of ExoT is required for actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infection and Immunity 2000, 68:7100-7113.
36. AJ Vallis, V Finck-Barbancon, TL Yahr, DW Frank: Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect. Immun. 1999, 67:2040-2044.
37. JC Olson, JE Fraylick, EM McGuffie, KM Dolan, TL Yahr, DW Frank, TS Vincent: Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S. Infect Immun 1999, 67:2847-54.
38. R Alm, JS Mattick: Identification of a gene, pilV, required for type 4 fimbrial biogenesis in Pseudomonas aeruginosa, whose product possesses a pre-pilin-like leader sequence. Mol. Microbiol. 1995, 16:485-496.
39. PJ Kang, AR Hauser, G Apodaca, S Fleiszig, J Wiener-Kronish, K Mostov, JN Engel: Identification of Pseudomonas aeruginosa genes required for epithelial cell injury. Mol. Microbiol. 1997, 24:1249-1262.
40. E Frithz-Lindsten, Y Du, R Rosqvist, A Forsberg: Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol Microbiol 1997, 25:1125-1139.
41. J Comolli, A Hauser, L Waite, C Whitchurch, J Mattick, J Engel: PilU and PilT are required for cytotoxicity and virulence of Pseudomonas aeruginosa. Infect. Immun. 1999, 67.
42. SK Arora, AN Neely, B Blair, S Lory, R Ramphal: Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa burn wound infections. Infect Immun 2005, 73:4395-4398.
43. M Feldman, R Bryan, S Rajan, L Scheffler, S Brunnert, H Tang, A Prince: Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 1998, 66:43-51.
44. H Tang, M Kays, A Prince: Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect. Immun. 1995, 63:1278-1285.
45. G Apodaca, M Bomsel, R Lindstedt, J Engel, D Frank, K Mostov, J Wiener-Kronish: Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation defective host cells are resistant to bacterial killing. Infect. Immun. 1995, 63:1541-1551.
46. PV Liu: The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis: Identity of the lethal toxins produced in vitro and in vivo. J Infect Dis 1966, 116:481-489.
47. C Stover, X Pham, A Erwin, S Mizoguchi, P Warrener, M Hickey, F Brinkman, W Hufnagle, D Kowalik, M Lagrou, et al: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 2000, 406:959-64.
48. BW Holloway: Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 1955, 13:572-581.